Interaction of NF-κB and Wnt/β-catenin Signaling Pathways in Alzheimer's Disease and Potential Active Drug Treatments

Neurochem Res. 2021 Apr;46(4):711-731. doi: 10.1007/s11064-021-03227-y. Epub 2021 Feb 1.

Abstract

The most important neuropathological features of Alzheimer's disease (AD) are extracellular amyloid-β protein (Aβ) deposition, tau protein hyperphosphorylation and activation of neurometabolic reaction in the brain accompanied by neuronal and synaptic damage, and impaired learning and memory function. According to the amyloid cascade hypothesis, increased Aβ deposits in the brain to form the core of the senile plaques that initiate cascade reactions, affecting the synapses and stimulating activation of microglia, resulting in neuroinflammation. A growing number of studies has shown that NF-κB and Wnt/β-catenin pathways play important roles in neurodegenerative diseases, especially AD. In this review, we briefly introduce the connection between neuroinflammation-mediated synaptic dysfunction in AD and elaborated on the mechanism of these two signaling pathways in AD-related pathological changes, as well as their interaction. Based on our interest in natural compounds, we also briefly introduce and conduct preliminary screening of potential therapeutics for AD.

Keywords: Alzheimer’s disease; NF-κb; Natural compounds; Neuroinflammation; Synaptic dysfunction; Wnt/β-catenin.

Publication types

  • Review

MeSH terms

  • Alzheimer Disease / drug therapy*
  • Alzheimer Disease / physiopathology*
  • Animals
  • Biological Products / therapeutic use
  • Drugs, Chinese Herbal / therapeutic use
  • Humans
  • Inflammation / drug therapy
  • Inflammation / physiopathology
  • Microglia / metabolism
  • NF-kappa B p50 Subunit / metabolism*
  • Synapses / metabolism
  • Wnt Signaling Pathway / drug effects
  • Wnt Signaling Pathway / physiology*

Substances

  • Biological Products
  • Drugs, Chinese Herbal
  • NF-kappa B p50 Subunit
  • NFKB1 protein, human